Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.
about
Lamotrigine for chronic neuropathic pain and fibromyalgia in adultsLamotrigine for acute and chronic painRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitatiPathways in the diagnosis and management of diabetic polyneuropathyThe effectiveness of anticonvulsants in psychiatric disordersDiabetic neuropathy: mechanisms to managementTreating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Painful diabetic neuropathy: advantage of novel drugs over old drugs?Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Diabetic neuropathy: clinical manifestations and current treatments.Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy.Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials.Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain.Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.Open-label trial of lamotrigine focusing on efficacy in vulvodyniaVoltage-gated sodium channel blockers for the treatment of neuropathic pain.Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.Predictors of premature discontinuation of treatment in multiple disease statesPain associated with diabetic peripheral neuropathy: a review of available treatmentsDiabetic painful and insensate neuropathy: pathogenesis and potential treatments.Sodium channel blockers for neuropathic pain.Clinical Approach to the Treatment of Painful Diabetic Neuropathy.Adjuvant analgesics in cancer pain: a review.Ion channel drug discovery: challenges and future directions.Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy.Diabetic neuropathy and oxidative stress: therapeutic perspectives.Management options for established chemotherapy-induced peripheral neuropathy.Painful diabetic neuropathy: an updateAn investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.Understanding and treating painful diabetic neuropathy: time for a paradigm shift.Choosing drugs for the treatment of diabetic neuropathy.Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.A Randomized Double-Blind Placebo-Controlled Study to Compare Preemptive Analgesic Efficacy of Novel Antiepileptic Agent Lamotrigine in Patients Undergoing Major Surgeries.The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.Comparative Pre-Emptive Analgesic Efficacy Study of Novel Antiepileptic Agents Lamotrigine and Topiramate in Patients Undergoing Major Surgeries at a Tertiary Care Hospital: A Randomized Double Blind Clinical Trial.Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.Evaluation of symptom heterogeneity in neuropathic pain using assessments of sensory functions.
P2860
Q24201979-53E27C37-57BA-4B30-82FB-E46BBFE3FFDBQ24236694-AB538DDD-D35E-4C30-B092-42EFC53D7A40Q24616897-D1F352E0-D59B-4BCF-8263-A80812E717B3Q24632313-ED0EEA4C-6A14-43B7-8638-1C3C0D93EF07Q28082465-1C777CCF-9402-41CF-8C47-156C8D62D9EFQ28744504-4384164F-24BC-4B14-8AF8-26E2A868B335Q33554384-5C068EA5-8475-4894-B6AE-909C02D9220AQ33583006-F14537BD-F7A1-453E-9C89-F3AEB4FB2C68Q33610824-B625412A-4F31-4AD7-8712-1B649A29B308Q33870062-123672EC-71CA-4463-B610-1DF6A3ADCC76Q34110857-9EBB1291-6E2E-43AA-BA68-71A6FBCCC2FBQ34275990-44CB71FC-72F5-4A5A-918C-DBA599048DB2Q34670046-7293D922-3565-4221-B320-23F64F7F2D44Q35694450-33D20D9A-8797-4BA1-90E5-F687F3AD5190Q36078321-20252C7C-655F-4F51-AE54-6C1D0E342FD4Q36213567-E05C4096-2D9C-4394-AC16-99A8A5E6811BQ36364962-189D4D39-B490-4A58-88E1-616B95A82ED4Q36998857-0D7A3D3E-F336-4CEB-9A60-A225402CABEBQ37283665-6F39C22F-C893-4778-BB0E-947BF328BB25Q37423705-0D855143-2F61-452E-9CB9-43A10DBDF490Q37596278-CC8BB96D-5856-4074-A9C6-7DFB29D27EFBQ37605348-A77B3C6F-7BB3-4DE3-851C-82408C3B9669Q37729164-7DC95E43-7205-46C7-BA88-65902E01CD55Q37895130-6F58BF86-5262-40BD-AC25-D2B3582BE2B8Q37895398-46AE82F3-5B24-49AA-B635-74E6A6091B46Q37998135-4233EB23-86AF-4A50-8153-923278E12DD3Q38093664-9D7F837E-4C22-4BF0-A494-541B1E5C9FFAQ38112117-1073F6D6-AAE4-46AC-807B-979DAB697944Q38216217-2495F2E7-015A-4E27-889D-36F48D0ADC49Q38247947-FC4FA40D-689E-4CB3-9715-4657517B2CECQ38307489-CC3A98B8-0212-41C3-9B73-0CED7207237AQ38394422-A09C141A-5C19-41AA-96BF-B0541F47CBCEQ38544804-7597D2D8-1964-4155-BE05-F54FF76D4C7DQ38652570-9E8ACBF5-6CAF-4C36-86D1-D271B93182F3Q38798588-1AA3F434-CB80-46A2-A879-7734519D247DQ39003517-2FFC0453-5080-41C2-ACFA-9100EEB54150Q39274579-D8F8718D-3024-42EF-AB1C-E5AB71D4250DQ39307501-83855707-2AD9-4409-AAAF-7535A654B625Q39940045-99CF5D66-C83C-4952-855C-3A155458161EQ41604404-54D7F62E-846E-427B-BB7C-F5351E220586
P2860
Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Lamotrigine for treatment of p ...... d, placebo-controlled studies.
@en
Lamotrigine for treatment of p ...... d, placebo-controlled studies.
@nl
type
label
Lamotrigine for treatment of p ...... d, placebo-controlled studies.
@en
Lamotrigine for treatment of p ...... d, placebo-controlled studies.
@nl
prefLabel
Lamotrigine for treatment of p ...... d, placebo-controlled studies.
@en
Lamotrigine for treatment of p ...... d, placebo-controlled studies.
@nl
P2093
P1433
P1476
Lamotrigine for treatment of p ...... d, placebo-controlled studies.
@en
P2093
Aaron I Vinik
Beth Safirstein
Clinton Corder
David Blum
Joanne Grainger
Jonathan White
Kerri Wilks
Louis Kirby
Marianne Silver
Michael Tuchman
P304
P356
10.1016/J.PAIN.2006.09.040
P407
P577
2006-12-11T00:00:00Z